Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Gut Microbiome-Lung Tissue Communication Through Short-Chain Fatty Acid Analysis
Published on: June 21, 2024
Short-chain fatty acids in cancer pathogenesis
Mark A Feitelson1, Alla Arzumanyan2, Arvin Medhat3
1Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA. feitelso@temple.edu.
Short-chain fatty acids (SCFAs) produced by gut bacteria help maintain health. Restoring SCFA levels can combat cancer by reducing inflammation and blocking tumor cell growth, offering a potential new therapeutic strategy.
Area of Science:
- Microbiology
- Immunology
- Oncology
- Metabolomics
Background:
- Cancer represents a shift away from homeostasis, influenced by factors like infections, mutations, diet, and carcinogens.
- Gut bacteria-produced short-chain fatty acids (SCFAs) are crucial for maintaining health and homeostasis.
- Gut dysbiosis, marked by low SCFAs and a leaky gut, is a risk factor for numerous cancer types.
Purpose of the Study:
- To investigate the role of SCFAs in cancer pathogenesis and their potential as a therapeutic agent.
- To elucidate the mechanisms by which SCFAs modulate inflammation and cancer cell proliferation.
- To compare the efficacy and safety of SCFAs with other microbiome-based interventions like probiotics and fecal transplants.
Main Methods:
- Review of existing literature on SCFA production, gut dysbiosis, and cancer.
- Analysis of SCFA's anti-inflammatory mechanisms, including NF-κB inhibition and cytokine modulation.
- Examination of SCFA's epigenetic effects on cancer-related genes and signaling pathways (Wnt, Hedgehog, Hippo, Notch).
- Assessment of SCFA's impact on cancer stem cell proliferation and tumor suppressor gene expression (PTEN, p53).
Main Results:
- SCFAs attenuate inflammation by inhibiting pro-inflammatory pathways and promoting anti-inflammatory cytokines.
- SCFAs exert epigenetic effects, influencing genes and pathways critical to cancer development.
- SCFAs demonstrate selective toxicity towards tumor cells while sparing healthy tissue, and target multiple hallmarks of cancer.
- SCFAs were found to block cancer stem cell proliferation, potentially preventing cancer development or relapse.
Conclusions:
- SCFAs play a significant role in maintaining gut homeostasis and possess anti-cancer properties.
- SCFA administration may offer a safe and effective strategy to delay or prevent various tumor types by re-establishing homeostasis.
- SCFAs present advantages over probiotics and fecal transplants due to their targeted toxicity and ability to modulate key cancer pathways.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

